Le Bar S/Loup, France

Uwe Reichert


Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 262(Granted Patents)


Location History:

  • Le Bar S/Loup, FR (1994 - 1996)
  • Pont Du Loup, FR (1998 - 2004)

Company Filing History:


Years Active: 1994-2004

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations in Dermatological Research by Uwe Reichert

Introduction

Uwe Reichert, a prominent inventor based in Le Bar S/Loup, France, has made significant contributions to the field of dermatology through his innovative inventions. With a total of 12 patents to his name, he is recognized for his groundbreaking research that focuses on the application of specific agonist ligands for enhancing apoptosis in skin cells.

Latest Patents

Among Uwe Reichert's latest patents is the invention concerning the "Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis." This invention delves into pharmaceutical and cosmetic compositions that incorporate agonist ligands specific to RAR-γ type receptors. The primary aim of this invention is to combat photo-induced and chronological aging of the skin by using specific agonist ligands in effective amounts. Additionally, his other patent concerning the same agonist ligands emphasizes their role in preparing pharmaceutical compositions to increase the rate of apoptosis in cell populations, addressing diseases linked with insufficient apoptosis rates. This innovative approach extends to cosmetic applications aimed at preventing and controlling skin aging.

Career Highlights

Throughout his career, Uwe Reichert has made significant strides in the field of dermatological research. His work, particularly in the development of innovative compositions, has established him as a leader in combating skin aging processes. His dedication to advancing dermatological science is evident in his numerous patents that reflect his commitment to improving skincare and medical treatment solutions.

Collaborations

Uwe Reichert has collaborated with esteemed professionals in his field, including Braham Shroot and Paul Grimaldi. These partnerships have undoubtedly enriched his research endeavors and furthered the impact of his innovative patents within the dermatological community.

Conclusion

In conclusion, Uwe Reichert stands out as a notable inventor in dermatological innovations, with a robust portfolio of patents that address critical issues related to skin aging and cell apoptosis. His work serves as a testament to the potential of targeted agonist ligands in creating effective pharmaceutical and cosmetic solutions for skin health, showcasing the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…